Preoperative Gastric Content With Ultrasound Assessment in Patients Taking GLP1 Agonists

Overview

About this study

The purpose of this study is to perform bedside gastric point of care ultrasound (POCUS) exams to assess the gastric volume and content (clear liquids vs solid food) perioperatively in patients who take glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • GLP 1 patient group: any patient on GLP1 agonists that are dosed once per week (semaglutide, dulaglutide, tirzepatide), for all indications.
  • Control group (No GLP 1 patients): any patient not on GLP1 agonists that are dosed once per week, for all indications.

Exclusion Criteria:

  • Patients with gastric bypass or any other gastric surgery.
  • Large hiatal hernia.
  • Patients with large ascites.
  • Patients on peritoneal dialysis.
  • Emergency surgery.
  • Pre-existing diagnosis of gastroparesis.

Note: Other protocol defined Inclusion/Exclusion criteria may apply.

Eligibility last updated 8/18/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Hari Kalagara, M.B.B.S., M.D.

Open for enrollment

Contact information:

Alyssa Sapin

Sapin.Alyssa@mayo.edu

More information

Publications

Publications are currently not available